Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide | 23 | 2022 | 287 | 4.070 |
Why?
|
| Kidney | 19 | 2023 | 322 | 3.680 |
Why?
|
| PPAR alpha | 8 | 2018 | 42 | 2.980 |
Why?
|
| Hypertension | 10 | 2023 | 770 | 2.040 |
Why?
|
| Sodium Chloride, Dietary | 5 | 2018 | 40 | 1.760 |
Why?
|
| Cytochrome P-450 Enzyme System | 8 | 2010 | 82 | 1.590 |
Why?
|
| Blood Pressure | 16 | 2022 | 613 | 1.450 |
Why?
|
| Renal Circulation | 9 | 2022 | 18 | 1.240 |
Why?
|
| Rats | 30 | 2022 | 3261 | 1.240 |
Why?
|
| Fumarates | 2 | 2023 | 11 | 1.160 |
Why?
|
| Endothelin-1 | 9 | 2010 | 54 | 1.130 |
Why?
|
| Rats, Sprague-Dawley | 25 | 2016 | 1534 | 1.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2018 | 81 | 1.060 |
Why?
|
| Animals | 39 | 2022 | 14307 | 0.920 |
Why?
|
| Vasodilation | 6 | 2007 | 65 | 0.860 |
Why?
|
| NG-Nitroarginine Methyl Ester | 8 | 2022 | 34 | 0.850 |
Why?
|
| Reperfusion Injury | 2 | 2016 | 53 | 0.790 |
Why?
|
| Arachidonic Acid | 5 | 2003 | 32 | 0.740 |
Why?
|
| Vasoconstriction | 7 | 2010 | 40 | 0.680 |
Why?
|
| Natriuresis | 5 | 2018 | 10 | 0.680 |
Why?
|
| Kidney Medulla | 3 | 2018 | 6 | 0.660 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2018 | 2 | 0.660 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 7 | 2010 | 9 | 0.610 |
Why?
|
| Neprilysin | 2 | 2010 | 7 | 0.610 |
Why?
|
| Protein Kinase C | 3 | 2010 | 110 | 0.600 |
Why?
|
| Glomerular Filtration Rate | 2 | 2016 | 137 | 0.580 |
Why?
|
| Angiotensin II | 5 | 2010 | 92 | 0.550 |
Why?
|
| Amiloride | 2 | 2022 | 16 | 0.550 |
Why?
|
| Sodium | 4 | 2022 | 101 | 0.530 |
Why?
|
| Aorta | 3 | 2007 | 161 | 0.530 |
Why?
|
| Male | 30 | 2018 | 18870 | 0.520 |
Why?
|
| Enzyme Inhibitors | 6 | 2010 | 396 | 0.510 |
Why?
|
| Nitric Oxide Synthase | 5 | 2018 | 103 | 0.500 |
Why?
|
| Kidney Glomerulus | 3 | 2007 | 80 | 0.500 |
Why?
|
| Free Radicals | 5 | 2010 | 72 | 0.490 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2013 | 7 | 0.480 |
Why?
|
| Signal Transduction | 5 | 2023 | 1802 | 0.480 |
Why?
|
| PPAR gamma | 4 | 2010 | 49 | 0.470 |
Why?
|
| Neovascularization, Physiologic | 1 | 2013 | 70 | 0.450 |
Why?
|
| Clofibrate | 6 | 2010 | 13 | 0.450 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2004 | 25 | 0.450 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 4 | 2010 | 11 | 0.420 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2011 | 8 | 0.410 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2011 | 13 | 0.410 |
Why?
|
| Mice, Knockout | 5 | 2018 | 897 | 0.390 |
Why?
|
| Desoxycorticosterone | 4 | 2021 | 9 | 0.390 |
Why?
|
| Hemodynamics | 3 | 2022 | 86 | 0.360 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2008 | 23 | 0.340 |
Why?
|
| Acetylcholine | 3 | 2006 | 68 | 0.340 |
Why?
|
| Oxidative Stress | 3 | 2013 | 874 | 0.330 |
Why?
|
| Indans | 2 | 2010 | 11 | 0.330 |
Why?
|
| Propionates | 2 | 2010 | 25 | 0.330 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2008 | 6 | 0.330 |
Why?
|
| Thiazides | 1 | 2008 | 2 | 0.320 |
Why?
|
| Hypertension, Renal | 1 | 2008 | 15 | 0.320 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 229 | 0.320 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 274 | 0.320 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 391 | 0.310 |
Why?
|
| Glycerol | 3 | 2007 | 29 | 0.310 |
Why?
|
| Proteinuria | 4 | 2013 | 48 | 0.300 |
Why?
|
| Isoproterenol | 2 | 2004 | 35 | 0.300 |
Why?
|
| Xanthine Oxidase | 1 | 2006 | 8 | 0.300 |
Why?
|
| Cyclosporine | 1 | 2006 | 26 | 0.290 |
Why?
|
| Vasodilator Agents | 3 | 2007 | 54 | 0.290 |
Why?
|
| Kidney Tubules | 2 | 2003 | 28 | 0.290 |
Why?
|
| Microsomes | 4 | 2010 | 52 | 0.280 |
Why?
|
| Antihypertensive Agents | 3 | 2021 | 284 | 0.280 |
Why?
|
| Oxygenases | 2 | 2003 | 3 | 0.280 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 184 | 0.260 |
Why?
|
| Dinoprostone | 1 | 2005 | 57 | 0.260 |
Why?
|
| Models, Animal | 4 | 2008 | 131 | 0.260 |
Why?
|
| Aging | 2 | 2006 | 639 | 0.250 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2010 | 63 | 0.250 |
Why?
|
| Fumarate Hydratase | 1 | 2023 | 1 | 0.240 |
Why?
|
| Thromboxane A2 | 3 | 2010 | 18 | 0.240 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 58 | 0.240 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2003 | 4 | 0.240 |
Why?
|
| Endothelial Cells | 1 | 2006 | 296 | 0.230 |
Why?
|
| Malates | 1 | 2022 | 2 | 0.230 |
Why?
|
| Antioxidants | 2 | 2007 | 386 | 0.230 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2018 | 29 | 0.220 |
Why?
|
| Mice | 5 | 2018 | 5668 | 0.220 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2002 | 9 | 0.220 |
Why?
|
| Cyclic AMP | 1 | 2003 | 125 | 0.220 |
Why?
|
| Mixed Function Oxygenases | 1 | 2002 | 29 | 0.220 |
Why?
|
| Phenylephrine | 3 | 2007 | 34 | 0.220 |
Why?
|
| Pergolide | 1 | 2002 | 2 | 0.210 |
Why?
|
| Ascorbic Acid | 4 | 2007 | 63 | 0.210 |
Why?
|
| Acetates | 1 | 2021 | 20 | 0.200 |
Why?
|
| Down-Regulation | 2 | 2018 | 420 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2005 | 984 | 0.190 |
Why?
|
| Pyrimidines | 2 | 2013 | 112 | 0.190 |
Why?
|
| Female | 6 | 2018 | 19873 | 0.180 |
Why?
|
| Sodium Chloride | 2 | 2010 | 52 | 0.180 |
Why?
|
| Brain | 1 | 2006 | 1268 | 0.170 |
Why?
|
| Transcription Factors | 1 | 2004 | 653 | 0.170 |
Why?
|
| Miconazole | 2 | 2013 | 4 | 0.170 |
Why?
|
| Behavioral Research | 1 | 2019 | 37 | 0.170 |
Why?
|
| Lipid Peroxides | 2 | 2010 | 16 | 0.170 |
Why?
|
| Kidney Cortex | 1 | 2018 | 7 | 0.170 |
Why?
|
| Diuresis | 1 | 2018 | 7 | 0.170 |
Why?
|
| Minority Health | 1 | 2019 | 81 | 0.170 |
Why?
|
| Vasoconstrictor Agents | 2 | 2010 | 38 | 0.160 |
Why?
|
| Naphthalenes | 2 | 2010 | 37 | 0.160 |
Why?
|
| Bradykinin | 2 | 2007 | 22 | 0.150 |
Why?
|
| Nitrates | 2 | 2010 | 35 | 0.150 |
Why?
|
| Sirolimus | 1 | 2016 | 58 | 0.140 |
Why?
|
| Thiazolidinediones | 2 | 2007 | 48 | 0.140 |
Why?
|
| Nitroprusside | 2 | 2006 | 13 | 0.140 |
Why?
|
| Autophagy | 1 | 2016 | 111 | 0.140 |
Why?
|
| Kidney Function Tests | 2 | 2008 | 30 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2019 | 371 | 0.120 |
Why?
|
| Time Factors | 2 | 2013 | 1681 | 0.120 |
Why?
|
| Minority Groups | 1 | 2019 | 537 | 0.120 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2013 | 1 | 0.120 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2013 | 4 | 0.120 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2013 | 18 | 0.120 |
Why?
|
| Purines | 1 | 2013 | 37 | 0.120 |
Why?
|
| Osteopontin | 1 | 2013 | 35 | 0.120 |
Why?
|
| Collagen Type IV | 1 | 2013 | 48 | 0.120 |
Why?
|
| Nitrites | 2 | 2010 | 38 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 240 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 383 | 0.110 |
Why?
|
| Biological Transport | 2 | 2004 | 175 | 0.110 |
Why?
|
| Creatinine | 2 | 2010 | 101 | 0.110 |
Why?
|
| Zebrafish | 1 | 2013 | 118 | 0.110 |
Why?
|
| Indoles | 1 | 2013 | 154 | 0.110 |
Why?
|
| Kidney Diseases | 1 | 2013 | 159 | 0.100 |
Why?
|
| Myocardium | 1 | 2013 | 224 | 0.100 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 59 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 968 | 0.100 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2010 | 39 | 0.090 |
Why?
|
| Sus scrofa | 1 | 2010 | 21 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 120 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2010 | 156 | 0.090 |
Why?
|
| Microvessels | 1 | 2010 | 31 | 0.090 |
Why?
|
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2009 | 6 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2010 | 212 | 0.090 |
Why?
|
| Plasmids | 1 | 2009 | 233 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2008 | 20 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 430 | 0.080 |
Why?
|
| Diuretics | 1 | 2008 | 49 | 0.080 |
Why?
|
| Humans | 4 | 2023 | 34853 | 0.080 |
Why?
|
| Organ Size | 1 | 2008 | 148 | 0.080 |
Why?
|
| Base Sequence | 1 | 2009 | 932 | 0.080 |
Why?
|
| Drug Resistance | 1 | 2008 | 93 | 0.080 |
Why?
|
| Amidines | 1 | 2006 | 3 | 0.070 |
Why?
|
| Microcirculation | 1 | 2006 | 39 | 0.070 |
Why?
|
| Muscle Tonus | 1 | 2006 | 6 | 0.070 |
Why?
|
| Inflammation | 1 | 2011 | 577 | 0.070 |
Why?
|
| Muscle Relaxants, Central | 1 | 2006 | 5 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1490 | 0.070 |
Why?
|
| rho-Associated Kinases | 1 | 2006 | 30 | 0.070 |
Why?
|
| Arginine | 1 | 2006 | 62 | 0.070 |
Why?
|
| Swine | 1 | 2006 | 182 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2006 | 57 | 0.070 |
Why?
|
| Nitriles | 1 | 2006 | 66 | 0.070 |
Why?
|
| Biological Factors | 1 | 2005 | 6 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2010 | 1442 | 0.070 |
Why?
|
| Amides | 1 | 2006 | 66 | 0.070 |
Why?
|
| Triazoles | 1 | 2006 | 85 | 0.070 |
Why?
|
| Body Weight | 1 | 2008 | 404 | 0.070 |
Why?
|
| Pyridines | 1 | 2006 | 113 | 0.070 |
Why?
|
| Systole | 1 | 2005 | 65 | 0.070 |
Why?
|
| Hydrazines | 1 | 2005 | 21 | 0.070 |
Why?
|
| Indomethacin | 1 | 2005 | 24 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2005 | 34 | 0.070 |
Why?
|
| Xanthine | 1 | 2004 | 3 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2005 | 71 | 0.060 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2004 | 4 | 0.060 |
Why?
|
| Splanchnic Circulation | 1 | 2003 | 4 | 0.060 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2004 | 27 | 0.060 |
Why?
|
| Mesenteric Arteries | 1 | 2003 | 18 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2003 | 24 | 0.060 |
Why?
|
| Epoxy Compounds | 1 | 2003 | 14 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2003 | 51 | 0.060 |
Why?
|
| Obesity | 1 | 2011 | 965 | 0.060 |
Why?
|
| Prostaglandins | 1 | 2003 | 25 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2004 | 528 | 0.060 |
Why?
|
| Glucose | 1 | 2004 | 217 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 160 | 0.050 |
Why?
|
| Rubidium Radioisotopes | 1 | 2002 | 2 | 0.050 |
Why?
|
| Receptor, Endothelin A | 1 | 2002 | 3 | 0.050 |
Why?
|
| Receptors, Endothelin | 1 | 2002 | 7 | 0.050 |
Why?
|
| Superoxides | 1 | 2002 | 51 | 0.050 |
Why?
|
| Dopamine Agonists | 1 | 2002 | 29 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1530 | 0.050 |
Why?
|
| Kinetics | 1 | 2002 | 650 | 0.050 |
Why?
|
| Urodynamics | 1 | 2000 | 4 | 0.050 |
Why?
|
| Homeostasis | 1 | 2000 | 172 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2019 | 75 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2000 | 147 | 0.040 |
Why?
|
| Research Personnel | 1 | 2019 | 133 | 0.040 |
Why?
|
| Cultural Diversity | 1 | 2019 | 158 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 416 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2019 | 583 | 0.030 |
Why?
|
| Reactive Nitrogen Species | 1 | 2010 | 10 | 0.020 |
Why?
|
| Glomerular Basement Membrane | 1 | 2010 | 9 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2009 | 31 | 0.020 |
Why?
|
| United States | 1 | 2019 | 3894 | 0.020 |
Why?
|
| Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2007 | 2 | 0.020 |
Why?
|
| Thromboxane B2 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Renal Artery | 1 | 2007 | 7 | 0.020 |
Why?
|
| Dinoprost | 1 | 2007 | 22 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2007 | 63 | 0.020 |
Why?
|
| Catalase | 1 | 2007 | 106 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 149 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 127 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 642 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2010 | 486 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2007 | 152 | 0.020 |
Why?
|
| Gene Expression | 1 | 2007 | 639 | 0.020 |
Why?
|
| Calcium | 1 | 2003 | 445 | 0.010 |
Why?
|